Skip to content
10-Q

Quarterly Report

HARMONY BIOSCIENCES HOLDINGS, INC. HRMY

0001104659-26-056720

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 57.89M sh
Shares Diluted Q1 2026 · Mar 31, 2026 58.78M sh
Shares Diluted Q1 2026 · Mar 31, 2025 58.52M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $27.76M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $33.99M
Long Term Debt Q1 2026 · Mar 31, 2026 $138.81M
Long Term Debt Q1 2026 · Dec 31, 2025 $143.66M
Short Term Debt Q1 2026 · Mar 31, 2026 $20M
Short Term Debt Q1 2026 · Dec 31, 2025 $20M
Short Term Investments Q1 2026 · Mar 31, 2026 $51.52M
Short Term Investments Q1 2026 · Dec 31, 2025 $22.84M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $589.4M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $752.5M
Stockholders Equity Q1 2026 · Mar 31, 2026 $910.35M
Stockholders Equity Q1 2026 · Dec 31, 2025 $870.22M
Stockholders Equity Q1 2026 · Mar 31, 2025 $720.53M
Stockholders Equity Q1 2026 · Dec 31, 2024 $659.16M
Current Liabilities Q1 2026 · Mar 31, 2026 $217.34M
Current Liabilities Q1 2026 · Dec 31, 2025 $252.13M
Total Liabilities Q1 2026 · Mar 31, 2026 $361.48M
Total Liabilities Q1 2026 · Dec 31, 2025 $401.41M
Current Assets Q1 2026 · Mar 31, 2026 $778.82M
Current Assets Q1 2026 · Dec 31, 2025 $907.01M
Total Assets Q1 2026 · Mar 31, 2026 $1.27B
Total Assets Q1 2026 · Dec 31, 2025 $1.27B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.55
Eps Diluted Q1 2026 · Mar 31, 2025 $0.78
Eps Basic Q1 2026 · Mar 31, 2026 $0.56
Eps Basic Q1 2026 · Mar 31, 2025 $0.79
Sga Expense Q1 2026 · Mar 31, 2026 $32.51M
Sga Expense Q1 2026 · Mar 31, 2025 $31.24M
Rd Expense Q1 2026 · Mar 31, 2026 $69.38M
Rd Expense Q1 2026 · Mar 31, 2025 $34.54M
Net Income Q1 2026 · Mar 31, 2026 $32.49M
Net Income Q1 2026 · Mar 31, 2025 $45.56M
Operating Income Q1 2026 · Mar 31, 2026 $37.29M
Operating Income Q1 2026 · Mar 31, 2025 $56.25M
Gross Profit Q1 2026 · Mar 31, 2026 $170.88M
Gross Profit Q1 2026 · Mar 31, 2025 $152.74M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $44.51M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $31.99M
Revenue Q1 2026 · Mar 31, 2026 $215.39M
Revenue Q1 2026 · Mar 31, 2025 $184.73M
Capex Q1 2026 · Mar 31, 2025 $128K